# VitaFlow® Transcatheter Aortic Valve Replacement System Pre-market Trial Long Term Follow Up （VITAL）

> **NCT05977257** · — · NOT_YET_RECRUITING · sponsor: **Shanghai MicroPort CardioFlow Medtech Co., Ltd.** · enrollment: 89 (estimated)

## Conditions studied

- Aortic Valve Disease
- Aortic Valve Stenosis

## Interventions

- **DEVICE:** VitaFlow® Transcatheter Aortic Valve Replacement System

## Key facts

- **NCT ID:** NCT05977257
- **Lead sponsor:** Shanghai MicroPort CardioFlow Medtech Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2023-07-30
- **Primary completion:** 2025-10-30
- **Final completion:** 2028-10-30
- **Target enrollment:** 89 (ESTIMATED)
- **Last updated:** 2023-08-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05977257

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05977257, "VitaFlow® Transcatheter Aortic Valve Replacement System Pre-market Trial Long Term Follow Up （VITAL）". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05977257. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*